Work

A randomized phase III study of immune checkpoint inhibition with chemotherapy in treatment-naive metastatic anal cancer patients: A trial of the ECOG-ACRIN cancer research group (EA2176).

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.tps3614

Authors: Marc Thomas Roth, Paul J. Catalano, Kristen Keon Ciombor, Al Bowen Benson, Xin Yao, Rona Yaeger, Mohamed E. Salem, Van K. Morris, David H. Henry, Jennifer G. Whisenant, Peter J. O'Dwyer, Cathy Eng

Institutions: Vanderbilt University, Vanderbilt-Ingram Cancer Center, Dana-Farber Cancer Institute, Northwestern Medicine, Memorial Sloan Kettering Cancer Center, Levine Cancer Institute, The University of Texas MD Anderson Cancer Center, Pennsylvania Hospital, University of Pennsylvania

Language: English

Topic: Colorectal and Anal Carcinomas

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3170110464

Cites:

Cited by: 8

Related to: 10